Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01955941 · ClinicalTrials.gov registry record
Vascular Response to Brachytherapy Using Functional OCT
A clinical trial, sponsored by OHSU Knight Cancer Institute.
- Completed
- Registry status
- 49
- Enrollment target
NCT01955941 is a clinical trial that has completed, run by OHSU Knight Cancer Institute. The registered enrollment target is 49 participants.
The verdict
NCT01955941 has completed, sponsored by OHSU Knight Cancer Institute.
- COMPLETED
- Registry status
- 49 participants
- Enrollment target
Study Summary
The purpose of this study is to learn how blood flows to tumors in patients treated with I-125 plaque brachytherapy for uveal melanoma.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2013-10 |
| Est. Completion | 2021-11-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01955941
The ClinicalTrials.gov registry entry for NCT01955941 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is OHSU Knight Cancer Institute, which has 211 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01955941 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01955941 about?
NCT01955941 is a clinical study titled "Vascular Response to Brachytherapy Using Functional OCT". The purpose of this study is to learn how blood flows to tumors in patients treated with I-125 plaque brachytherapy for uveal melanoma.
What is the current status of trial NCT01955941?
This trial is currently completed. The enrollment target is 49 participants. The study started on 2013-10. Estimated completion is 2021-11-22.
Who is sponsoring clinical trial NCT01955941?
This trial is sponsored by OHSU Knight Cancer Institute, which has 211 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.